First patients in Germany treated with Delcath Hepatic CHEMOSAT Delivery System

Delcath Systems Inc NASDAQ DCTH announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital a premier European cancer treatment and research center located in Frankfurt The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011

Two patients were treated for inoperable liverdominant metastases one from cutaneous melanoma and one from breast cancer The treating physicians reported that both patients were treated successfully without procedurerelated complications

Dr Thomas J Vogl Director of the Institute for Diagnostic and Interventional Radiology at JW Goethe said We believe this technology has significant potential to help control cancers in the liver Were pleased to be the first cancer center to begin offering this important treatment option to patients in Germany and are eager to further explore its role in the treatment of multiple tumor types including breast cancer

Delcaths partnership with JW Goethe reinforces the potential of CHEMOSAT said Eamonn P Hobbs president and CEO of Delcath We recently treated our first patients in Milan and are eager to continue our expansion across Europe Opening another CHEMOSAT treatment center and treating patients in the continents largest market is another step forward in the commercialization of this technology

Date : 27 Mar, 2012
Reference : http://www.news-medical.net/news/20120227/First-patients-in-Germany-treated-with-Delcath-Hepatic-CHE

Back to News
Featured Hospitals Listing
MIOT Hospitals
4/112, Mount Poonamalle Road Manapakkam Chennai Tamil Nadu (India)
Phone : 044 2249 2288
Email : hip@miothospitals.com
Website URL : Available